Skip to content

Effects of Probiotics on Improving the Gastrointestinal Function and Intestinal Bacterial Flora

Effects of Probiotics on Improving the Gastrointestinal Function and Intestinal Bacterial Flora

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01428999
Enrollment
48
Registered
2011-09-05
Start date
2011-09-30
Completion date
2012-04-30
Last updated
2011-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Function, Intestinal Bacteria Flora

Keywords

probiotics, gastrointestinal function, intestinal bacteria flora

Brief summary

The purpose of this study is to evaluate the effect of combined probiotics to improve the gastrointestinal function and intestinal bacteria flora

Detailed description

Probiotics were known to improve gastrointestinal function before. This is a single-blind placebo control clinical study. We will perform gastrointestinal function questionnaire and collect stool as baseline data before the study (0-week). Then healthy subjects will be randomized to two groups. Experimental: probiotics 1 pack bid for 3 weeks. Probiotics : (AB-kefir):Lactobacillus acidophilus,Bifidobacterium longum,Lactobacillus paracasei,Lactobacillus rhamnosus,Lactobacillus fermentum,Streptococcus thermophilus,Lactobacillus helveticus,Kluyveromyces fragilis. Other components include starch,oligosaccharide,yeast powder, superior standard spice, calcium pantothenate, VitB1, VitB12, biotin and folic acid. Placebo group: placebo 1 pack bid for 3 weeks. Placebo: Except the probiotics (AB-kefir),the other components are the same with study group. Then gastrointestinal function questionnaire and stool collection will be performed at the end of 1st, 2nd, 3rd, and 4th weeks after starting the study.

Interventions

DIETARY_SUPPLEMENTprobiotics

probiotics 1 pack (2g) bid for three weeks

Sponsors

National Science and Technology Council, Taiwan
CollaboratorOTHER_GOV
National Cheng-Kung University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy people who are aged between 20 and 40 years

Exclusion criteria

* 1\. People who use probiotics medication and food that can inhibit bacteria growth within one month before the study 2. People who have active infection 3. People who have active or chronic gastro-intestinal disease 4. People who have diarrhea within two weeks before the study 5. People who are drug or alcohol abuser 6. People who are poor compliance

Design outcomes

Primary

MeasureTime frameDescription
Changes of gastrointestinal function after probiotics use28 daysChanges of gastrointestinal function, such as constipation, abdominal distension and appetite after proiotics and placebo use.

Secondary

MeasureTime frameDescription
Changes of intestinal bacteria flora after probiotics use28 days1. Changes of intestinal bacteria flora: (1) aerobic bacteria count (2) anaerobic bacteria count (3) Bifidobacterium count (4) Clostridium perfringens count (5) Staphylococcus aureus count (6) E. coli and K. pneumoniae count 2. The ratio for the antibiotics resistant bacteria ( such as Vancomycin-resistant Enterococcus,third-generation cephalosporin resistance E. coli, Methicillin-resistant Staphylococcus aureous, Extended-spectrum beta lactamase E. coli and K. pneumoniae) 3. Changes of the bacteria virulence factors for the intestinal E. coli and K. pneumonia

Countries

Taiwan

Contacts

Primary ContactMing-Cheng Wang, MD
wangmc@mail.ncku.edu.tw886-6-2353535
Backup ContactAn-bang Wu, MD
anbang@mail.ncku.edu.tw886-6-2353535

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026